(Q38092017)

28 August 2017

Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension (English)

1 reference

28 August 2017

0 references

1 reference

2

1 reference

28 August 2017

Luis M Ruilope

4

0 references

author name string

César Cerezo

series ordinal

1

1 reference

PubMed ID

23519746

28 August 2017

Manuel Praga

series ordinal

3

1 reference

28 August 2017

1 June 2013

1 reference

Current Hypertension Reports

28 August 2017

1 reference

28 August 2017

15

1 reference

28 August 2017

3

1 reference

28 August 2017

196-203

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-013-0337-4

28 August 2017

0 references

cites work

Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Pre-diabetes, metabolic syndrome, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Adipokines as novel biomarkers and regulators of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Reliability of doctors' anthropometric measurements to detect obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Metabolic implications of body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Cigarette smoking and increased central adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Why visceral fat is bad: mechanisms of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Body fat distribution and risk of cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Ectopic fat depots and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Physical activity and coronary heart disease in women: is "no pain, no gain" passé?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Bariatric surgery and long-term cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Impaired fasting glucose and impaired glucose tolerance: implications for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Racial differences in abdominal depot–specific adiposity in white and African American adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-013-0337-4

Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study

21 January 2018

1 reference

12 December 2020

The metabolic syndrome: is this diagnosis necessary?

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

2007 ESH‐ESC Guidelines for the management of arterial hypertension

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease

1 reference

12 December 2020

Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry.

1 reference

12 December 2020

Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study

1 reference

12 December 2020

Prevalence of obesity in the United States, 2009-2010.

1 reference

12 December 2020

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

12 December 2020

Intrahepatic insulin exposure, intrahepatocellular lipid and regional body fat in nonalcoholic fatty liver disease

1 reference

12 December 2020

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

1 reference

12 December 2020

Comment on the provisional report from the WHO consultation

1 reference

12 December 2020

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

1 reference

12 December 2020

10.1007/S11906-013-0337-4

Identifiers

DOI

1 reference

PubMed ID

23519746

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23519746